Related Experiment Video

Updated: Jun 5, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease

Steven A Chance1, Linda Clover, Helena Cousijn

  • 1Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK. steven.chance@clneuro.ox.ac.uk

Cerebral Cortex (New York, N.Y. : 1991)
|January 18, 2011
PubMed

Insights

Brain cell minicolumn spacing changes are early indicators of cognitive decline in mild cognitive impairment (MCI) and Alzheimer's disease (AD). These microanatomical alterations correlate with cognitive function, particularly in association cortex.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Cognitive Aging

Background:

  • Few microanatomical measures reliably correlate with cognitive function in aging and Alzheimer's disease (AD), especially in early stages like mild cognitive impairment (MCI).
  • Cortical minicolumn organization has shown potential links to cognitive ability in non-human primates.

Purpose of the Study:

  • To investigate the correlation between cortical minicolumn organization and cognitive function in humans across aging, MCI, and AD.
  • To determine if microanatomical changes in minicolumns are detectable in early stages of neurodegeneration.

Main Methods:

  • Postmortem quantification of plaques, tangles, and minicolumns in association cortex (BA22) and primary auditory cortex (BA41) from control, MCI, and AD subjects.
  • Correlation analysis of minicolumn measures with premortem cognitive scores (mini-mental state examination, verbal fluency).

Main Results:

  • Selective reduction in minicolumn spacing (thinning) observed in normal aging, further pronounced in MCI and AD.
  • Minicolumn changes, particularly thinning and disruption, correlated significantly with cognitive decline.
  • The strongest relationship between minicolumns and cognition was found in association cortex, suggesting regional specificity.

Conclusions:

  • Microanatomical changes in cortical minicolumns are detectable in early stages of cognitive impairment (MCI).
  • Minicolumn alterations reflect regional vulnerability and differential involvement in AD-related cognitive deficits.
  • These findings highlight minicolumn organization as a potential biomarker for early AD detection and progression.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.